Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0757
E

Failure to Discontinue Duplicate Buspirone Orders Resulting in Excessive Dosing

Houston, Texas Survey Completed on 04-09-2025

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

A deficiency occurred when a resident with quadriplegia and generalized anxiety disorder received duplicate orders for Buspirone 5 mg, resulting in the medication being administered both two times a day and three times a day over a period of time. Record reviews showed that both orders were active and being administered concurrently, with documentation on the Medication Administration Records (MAR) confirming that the resident received both regimens. The issue was identified when a nurse placed a call to the physician to clarify the Buspirone orders, and the duplicate order was subsequently discontinued. Interviews with facility staff, including an LPN, medication aide, ADON, DON, and the Administrator, revealed that the previous Buspirone order should have been discontinued when the new order was entered, but this did not occur. Staff acknowledged the presence of duplicate orders and the risk of medication errors, with the facility's policy indicating that new physician orders are to be reviewed for accuracy during daily clinical meetings. At the time of observation, the resident was alert and showed no signs of distress, and did not report any concerns regarding his medications.

An unhandled error has occurred. Reload 🗙